Cargando…

A novel treatment for metastatic lymph nodes using lymphatic delivery and photothermal therapy

Systemic delivery of an anti-cancer agent often leads to only a small fraction of the administered dose accumulating in target sites. Delivering anti-cancer agents through the lymphatic network can achieve more efficient drug delivery for the treatment of lymph node metastasis. We show for the first...

Descripción completa

Detalles Bibliográficos
Autores principales: Oladipo, Adewale O., Oluwafemi, Oluwatobi S., Songca, Sandile P., Sukhbaatar, Ariunbuyan, Mori, Shiro, Okajima, Junnosuke, Komiya, Atsuki, Maruyama, Shigenao, Kodama, Tetsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5377366/
https://www.ncbi.nlm.nih.gov/pubmed/28368042
http://dx.doi.org/10.1038/srep45459
_version_ 1782519301977145344
author Oladipo, Adewale O.
Oluwafemi, Oluwatobi S.
Songca, Sandile P.
Sukhbaatar, Ariunbuyan
Mori, Shiro
Okajima, Junnosuke
Komiya, Atsuki
Maruyama, Shigenao
Kodama, Tetsuya
author_facet Oladipo, Adewale O.
Oluwafemi, Oluwatobi S.
Songca, Sandile P.
Sukhbaatar, Ariunbuyan
Mori, Shiro
Okajima, Junnosuke
Komiya, Atsuki
Maruyama, Shigenao
Kodama, Tetsuya
author_sort Oladipo, Adewale O.
collection PubMed
description Systemic delivery of an anti-cancer agent often leads to only a small fraction of the administered dose accumulating in target sites. Delivering anti-cancer agents through the lymphatic network can achieve more efficient drug delivery for the treatment of lymph node metastasis. We show for the first time that polymeric gold nanorods (PAuNRs) can be delivered efficiently from an accessory axillary lymph node to a tumor-containing proper axillary lymph node, enabling effective treatment of lymph node metastasis. In a mouse model of metastasis, lymphatic spread of tumor was inhibited by lymphatic-delivered PAuNRs and near-infrared laser irradiation, with the skin temperature controlled by cooling. Unlike intravenous injection, lymphatic injection delivered PAuNRs at a high concentration within a short period. The results show that lymphatic administration has the potential to deliver anti-cancer agents to metastatic lymph nodes for inhibition of tumor growth and could be developed into a new therapeutic method.
format Online
Article
Text
id pubmed-5377366
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-53773662017-04-10 A novel treatment for metastatic lymph nodes using lymphatic delivery and photothermal therapy Oladipo, Adewale O. Oluwafemi, Oluwatobi S. Songca, Sandile P. Sukhbaatar, Ariunbuyan Mori, Shiro Okajima, Junnosuke Komiya, Atsuki Maruyama, Shigenao Kodama, Tetsuya Sci Rep Article Systemic delivery of an anti-cancer agent often leads to only a small fraction of the administered dose accumulating in target sites. Delivering anti-cancer agents through the lymphatic network can achieve more efficient drug delivery for the treatment of lymph node metastasis. We show for the first time that polymeric gold nanorods (PAuNRs) can be delivered efficiently from an accessory axillary lymph node to a tumor-containing proper axillary lymph node, enabling effective treatment of lymph node metastasis. In a mouse model of metastasis, lymphatic spread of tumor was inhibited by lymphatic-delivered PAuNRs and near-infrared laser irradiation, with the skin temperature controlled by cooling. Unlike intravenous injection, lymphatic injection delivered PAuNRs at a high concentration within a short period. The results show that lymphatic administration has the potential to deliver anti-cancer agents to metastatic lymph nodes for inhibition of tumor growth and could be developed into a new therapeutic method. Nature Publishing Group 2017-04-03 /pmc/articles/PMC5377366/ /pubmed/28368042 http://dx.doi.org/10.1038/srep45459 Text en Copyright © 2017, The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
Oladipo, Adewale O.
Oluwafemi, Oluwatobi S.
Songca, Sandile P.
Sukhbaatar, Ariunbuyan
Mori, Shiro
Okajima, Junnosuke
Komiya, Atsuki
Maruyama, Shigenao
Kodama, Tetsuya
A novel treatment for metastatic lymph nodes using lymphatic delivery and photothermal therapy
title A novel treatment for metastatic lymph nodes using lymphatic delivery and photothermal therapy
title_full A novel treatment for metastatic lymph nodes using lymphatic delivery and photothermal therapy
title_fullStr A novel treatment for metastatic lymph nodes using lymphatic delivery and photothermal therapy
title_full_unstemmed A novel treatment for metastatic lymph nodes using lymphatic delivery and photothermal therapy
title_short A novel treatment for metastatic lymph nodes using lymphatic delivery and photothermal therapy
title_sort novel treatment for metastatic lymph nodes using lymphatic delivery and photothermal therapy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5377366/
https://www.ncbi.nlm.nih.gov/pubmed/28368042
http://dx.doi.org/10.1038/srep45459
work_keys_str_mv AT oladipoadewaleo anoveltreatmentformetastaticlymphnodesusinglymphaticdeliveryandphotothermaltherapy
AT oluwafemioluwatobis anoveltreatmentformetastaticlymphnodesusinglymphaticdeliveryandphotothermaltherapy
AT songcasandilep anoveltreatmentformetastaticlymphnodesusinglymphaticdeliveryandphotothermaltherapy
AT sukhbaatarariunbuyan anoveltreatmentformetastaticlymphnodesusinglymphaticdeliveryandphotothermaltherapy
AT morishiro anoveltreatmentformetastaticlymphnodesusinglymphaticdeliveryandphotothermaltherapy
AT okajimajunnosuke anoveltreatmentformetastaticlymphnodesusinglymphaticdeliveryandphotothermaltherapy
AT komiyaatsuki anoveltreatmentformetastaticlymphnodesusinglymphaticdeliveryandphotothermaltherapy
AT maruyamashigenao anoveltreatmentformetastaticlymphnodesusinglymphaticdeliveryandphotothermaltherapy
AT kodamatetsuya anoveltreatmentformetastaticlymphnodesusinglymphaticdeliveryandphotothermaltherapy
AT oladipoadewaleo noveltreatmentformetastaticlymphnodesusinglymphaticdeliveryandphotothermaltherapy
AT oluwafemioluwatobis noveltreatmentformetastaticlymphnodesusinglymphaticdeliveryandphotothermaltherapy
AT songcasandilep noveltreatmentformetastaticlymphnodesusinglymphaticdeliveryandphotothermaltherapy
AT sukhbaatarariunbuyan noveltreatmentformetastaticlymphnodesusinglymphaticdeliveryandphotothermaltherapy
AT morishiro noveltreatmentformetastaticlymphnodesusinglymphaticdeliveryandphotothermaltherapy
AT okajimajunnosuke noveltreatmentformetastaticlymphnodesusinglymphaticdeliveryandphotothermaltherapy
AT komiyaatsuki noveltreatmentformetastaticlymphnodesusinglymphaticdeliveryandphotothermaltherapy
AT maruyamashigenao noveltreatmentformetastaticlymphnodesusinglymphaticdeliveryandphotothermaltherapy
AT kodamatetsuya noveltreatmentformetastaticlymphnodesusinglymphaticdeliveryandphotothermaltherapy